Navigation Links
Conference on developing new treatments for Tourette Syndrome

A conference is being organized at Washington D.C. on September 10, 11&12, by Yale School of Medicine. Several prominent scientists from Yale and other institutes will// meet to discover new ways to treat Tourette Syndrome (TS), a familial neurological disorder that begins in childhood and is characterized by chronic motor and vocal tics.

The characteristics of TS are blinking, facial movements, head jerking, throat clearing, coughing, grunting, and other brief noises. TS is not life threatening, but it can cause social isolation, particularly in children.

The chairperson of the forthcoming conference on identifying new treatments for TS, is Lawrence Scahill, professor of nursing and child psychiatry at Yale. Scientists from and outside the TS domain, will come together to discuss the latest findings in neuroscience to improvise the current treatment for tics.

"We have assembled a group of experts across a range of basic science and clinical fields who probably would not otherwise interact with each other," Scahill said. "By the end of the conference we hope to have new directions for the treatment for TS."

Over the past decade there has been a convergence of evidence from neuroimaging, neuropathology, genetics, and behavioral neuroscience about the neurobiology of TS. However, these advances have not yet had much impact on treatment. Research projects at Yale and at several other centers around the world are actively testing various treatments for TS, but new approaches are needed.

Once considered a rare and severe disorder, TS is now viewed as a disorder that ranges from mild to severe, affecting an estimated six of every 1,000 school-age children. Although many children will show a mild variant of TS, as many as one child in 1,000 in the United States may have tics that interfere with every day living.

The most effective medications are antipsychotic drugs with potent dopamine blocking pr operties. These medications, however, may be associated with sedation, weight gain, and neurological effects. Other types of medications have been used with variable results. "Clearly, it is time for recent findings from cutting edge neuroscience to inform new treatments for TS," Scahill said.

(Source: Eurekalert)
'"/>




Related medicine news :

1. International Conference On Malaria - Laveran To Genomics
2. African Conference to Combat AIDS
3. 5th European Breast Cancer Conference Talks about Everything from Patient to Oncologist
4. Consultation Conference to control HIV, TB and Malaria
5. Afghanistan Hosting A UN Funded Regional Health Conference
6. New Delhi to Host Conference on Accident & Emergency Medical Treatment
7. UN Conference Calls For Monitoring System To Check Bird Flu
8. National Autism Conference In US Expected To Draw Thousands In Attendance
9. Ayurvedic Treatment to be Focus of Conference
10. Health Ministers Conference on July 30
11. XVI International AIDS Conference To Be Held In Toronto In August
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: